[Not Available].

In the era of intrapartum chemoprophylaxis to reduce GBS, rates of early onset bacterial infection have declined in term newborns. New guidelines have been written in order to adapt our current practices to this epidemiological evolution and limit excessive exams and antibiotic administrations. The main point of these new guidelines consists in a clinical systematic surveillance in maternity for well appearing newborns instead of the current empiric antibiotic treatment. Advised biological exams are also detailed.